miércoles, 29 de abril de 2026

Did Kennedy just stack the deck on FDA oversight of peptides? It sure looks like it By Paul KnoepflerApril 29, 2026

https://www.statnews.com/2026/04/29/rfk-jr-peptides-upcoming-fda-policy-shift-compounding-drugs/ By Paul KnoepflerApril 29, 2026 Knoepfler is a professor of cell biology and human anatomy at UC Davis School of Medicine.

No hay comentarios: